Search

everythinglearnresearchcommunity

for

Search:↓

Certain long non-coding RNAs in cashmere goats affect hair growth when treated with a specific growth factor.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Understanding skin patterns can help us learn about skin diseases and their treatments.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

RNAi-based biopesticides could be safe and effective for pest control with careful development and risk assessment.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Oral zinc sulphate reduces dark hair color in mice.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Mobile phone radiation may cause DNA damage in human ear hair follicle cells.

Researchers found that certain RNA molecules might play a role in the growth of Cashmere goat hair.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.